Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 494

Results For "EU"

5996 News Found

UFDA approves first generic of Symbicort to treat asthma and COPD
Drug Approval | March 16, 2022

UFDA approves first generic of Symbicort to treat asthma and COPD

This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)


Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates
Biotech | March 16, 2022

Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates

Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer


Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
News | March 16, 2022

Bharat Biotech and Biofabri to develop and distribute novel TB vaccine

MTBVAC is a global public-private project that will be a milestone in the field of vaccinology


Boston Scientific opens second R&D centre in Pune
News | March 16, 2022

Boston Scientific opens second R&D centre in Pune

The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300


BSV invests in solar power project as part of it sustainability commitment
Sustainability | March 16, 2022

BSV invests in solar power project as part of it sustainability commitment

This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years


NuclixBio and PharmAbcine sign collaborative research agreement
Biotech | March 15, 2022

NuclixBio and PharmAbcine sign collaborative research agreement

Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies


I Peace triples GMP cell manufacturing by expanding CDMO facility
Biotech | March 15, 2022

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets


USFDA grants Orphan Drug Designation for Akantior
Biotech | March 15, 2022

USFDA grants Orphan Drug Designation for Akantior

SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets


Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
Biotech | March 15, 2022

Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation

Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder


Live Pharma Coalition to organise its first-ever conclave in Mumbai
News | March 15, 2022

Live Pharma Coalition to organise its first-ever conclave in Mumbai

The focus is to build collaborative learning and sharing ecosystem